Navigation Links
MIT's McGovern Institute researchers awarded $8.5M to study brain basis of autism and dyslexia
Date:1/31/2008

Two researchers at MITs McGovern Institute for Brain Research will head an ambitious new project to study the origins of autism and dyslexia, supported by a $8.5M grant from the Ellison Medical Foundation. The project leaders, Nancy Kanwisher and John Gabrieli, are prominent experts in neuroimaging and human brain development.

Autism and dyslexia are complex brain disorders that first appear in early childhood. Autism impairs social interactions and communication, and affected individuals may engage in bizarre and repetitive behaviors. Dyslexia is a learning disorder that manifests itself as reading difficulty despite adequate education and otherwise normal perceptual and intellectual abilities.

Little is known about the causes of either disorder, although both are highly heritable. In both cases, it is thought that the earlier treatments begin, the more effectively they help the child compensate. Thus, it is important to develop methods for early diagnosis, and scientists believe that non-invasive brain imaging may be a means to this end.

Human neuroimaging methods have advanced greatly over the last five years, and a major emphasis of the new project will be to translate these advances to pediatric neuroimaging. Brain imaging with young children presents many challenges, not least of which is their inability to lie still for long periods in the scanner. The McGovern investigators will collaborate with neuroimaging experts Larry Wald, Bruce Fischl and Ellen Grant at Massachusetts General Hospital (MGH), who will develop scanning coils designed specifically for childrens heads, along with new procedures to shorten scan times and methods to analyze data from brains that are not yet fully developed.

We expect these technological advances to radically improve pediatric neuroimaging and help us make major strides in understanding typical and atypical human brain development, comments Kanwisher, the Ellen Swallow Richards Professor of Cognitive Neuroscience. Kanwisher, a member of the National Academy of Sciences, will lead the work on autism. Gabrieli, who is the Grover Hermann Professor in Health Sciences and Technology and Cognitive Neuroscience, will lead the dyslexia component.

The researchers plan to study a cohort of children, scanning them at regular intervals to examine the development of brain systems that have been implicated in social cognition (for autism) or reading (for dyslexia). They hope to include children who, because of their family history, are at increased risk for autism or dyslexia and to compare them to controls with no special risk factors. The researchers will also look at children who have already been diagnosed, looking for telltale markers that could be useful for diagnosing and tracking the progression of the disorders. They also plan to examine the effects of therapeutic interventions, in the hope of identifying markers that will guide the development of more effective therapies. In the longer term, they hope to link their findings to future advances in understanding the genetics of these disorders. By combining both approaches, says Gabrieli, it may eventually be possible to develop genetic tests that will be easier and less expensive than brain scans.

Kanwisher and Gabrieli will also collaborate with Rebecca Saxe, Assistant Professor of Neurobiology in the MIT Department of Brain and Cognitive Sciences, who will focus on the development of neural mechanisms for social cognition to identify the earliest stages at which infants' brains become specialized to perceive other people and understand language. Other collaborators are Laura Schulz at MIT, April Benasich at Rutgers University, Maryanne Wolf at Tufts University, David Pauls and Matti Hamalainen at MGH, and Glenn Rosen and Albert Galaburda at Beth Israel Deaconess Medical Center.


'/>"/>

Contact: Charles Jennings
charlesj@mit.edu
617-324-3977
McGovern Institute for Brain Research
Source:Eurekalert

Related medicine news :

1. Sutter Admits: Closing St. Lukes Likely to Reduce Charity Care
2. Michael J. Fox Foundation Commits up to $3.8 Million to Develop Gene Silencing Neuroprotective Treatment for Parkinsons Disease
3. Takeda submits new drug application for alogliptin (syr-322) in the US
4. XTENT Submits CE Mark Registration to Market Custom NX(R) Drug-Eluting Stent System in Europe
5. ImaRx Therapeutics Submits Urokinase Data to FDA Supporting Extended Expiration Dating
6. Millennium Submits sNDA for VELCADE(R) (Bortezomib) for Injection for the Treatment of Front-Line Multiple Myeloma
7. ISTA Pharmaceuticals Submits New Drug Application for Xibrom(TM) QD (once-daily)
8. Health Care Bill Omits Access to Spiritual Care
9. Activating protein enhances average lifespan, limits age-related disease in mice
10. SGX Pharmaceuticals Submits Investigational New Drug Application for SGX523, a Highly Potent, Selective, Orally Bioavailable cMET Inhibitor
11. Gates Foundation Commits to Expansion of HIV Prevention in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their highest five-star rating to ... of individuals in the United States and Canada wear eyeglasses. Once considered to be ... vision and make a fashion statement. Even celebrities use glasses as a way of ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media ... give their videos a whole new perspective by using the title layers in ... Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women ... diagnosed with endometriosis. These women need a treatment plan to not only alleviate ... that can help for preservation of fertility and ultimately achieving a pregnancy. The ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Any dentist who has made ... the current process. Many of them do not even offer ... difficulties and high laboratory costs involved. And those who ARE ... at such a high cost that the majority of today,s ... Dr. Parsa Zadeh , founder of Dental Evolutions Inc. ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: RO, ... clearance for its Elecsys BRAHMS PCT (procalcitonin) assay as ... or septic shock. With this clearance, Roche is the ... fully integrated solution for sepsis risk assessment and management. ... bacterial infection and PCT levels in blood can aid ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... to their offering. The ... commercial environment for MedImmune to enter. The US ageing population ... to drive considerable growth for effective anti-influenza medications. The introduction ... considerably, but development is still in its infancy. ...
Breaking Medicine Technology: